Prestige Consumer Healthcare (PBH) Share-based Compensation (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Share-based Compensation came in at $2.7 million in Q4 2025, up 96.34% quarter-over-quarter from $1.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Share-based Compensation (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.7 million for Q4 2025.
- On a quarterly basis, Share-based Compensation changed N/A year-over-year to $2.7 million in Q4 2025; TTM through Dec 2025 was $13.5 million, a 41.36% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, down 20.36% from the prior year.
- Share-based Compensation grew to $2.7 million in Q4 2025 per PBH's latest filing, from $1.4 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.3 million in Q1 2025 and bottomed at -$4.7 million in Q1 2021.
- The 5-year median for Share-based Compensation is $2.8 million (2021), against an average of $2.1 million.
- Across the five-year window, Share-based Compensation slumped 339.65% in 2021 and jumped 231.88% in 2023, its largest moves.
- Year by year, Share-based Compensation stood at $2.2 million in 2021, then sank by 183.12% to -$1.9 million in 2022, then soared by 231.88% to $2.4 million in 2023, then dropped by 1.71% to $2.4 million in 2024, then grew by 13.79% to $2.7 million in 2025.
- Per Business Quant, the three latest PBH Share-based Compensation figures stand at $2.7 million (Q4 2025), $1.4 million (Q3 2025), and $4.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Jun 30, 2023 | 4.15 Mn |